Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Fochon Pharmaceuticals patents Bcl-2 inhibitors

Nov. 22, 2021

Biopolar Hongye (Nantong) Pharmaceutical synthesizes JAK2 inhibitors

Nov. 19, 2021

Beijing Tide Pharmaceutical identifies GTPase KRAS inhibitors

Nov. 19, 2021

Betta Pharmaceuticals patents new compounds for cancer

Nov. 19, 2021

Hangzhou Innogate Pharma divulges SYK and JAK2 kinase inhibitors

Nov. 19, 2021

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Nov. 18, 2021

Betta Pharmaceuticals identifies PTPN11 inhibitors

Nov. 18, 2021

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...